Comparative Pharmacology
Head-to-head clinical analysis: CLOPRA versus MOTEGRITY.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLOPRA versus MOTEGRITY.
CLOPRA vs MOTEGRITY
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Clopra (metoclopramide) is a dopamine D2 receptor antagonist and a 5-HT4 receptor agonist, enhancing gastrointestinal motility and having antiemetic effects via central and peripheral actions.
Prucalopride is a selective, high-affinity serotonin 5-HT4 receptor agonist that stimulates colonic motility by enhancing peristalsis and accelerating gastrointestinal transit.
Clopra (metoclopramide) 10 mg orally or intramuscularly 30 minutes before meals and at bedtime; maximum 30 mg/day. For intravenous administration, give 10 mg over 1-2 minutes.
2 mg orally once daily.
None Documented
None Documented
Terminal elimination half-life 6-8 hours (prolonged in renal impairment; up to 20 hours in severe CKD)
Clinical Note
moderateMetoclopramide + Haloperidol
"The risk or severity of adverse effects can be increased when Metoclopramide is combined with Haloperidol."
Clinical Note
moderateMetoclopramide + Quinagolide
"The therapeutic efficacy of Quinagolide can be decreased when used in combination with Metoclopramide."
Clinical Note
moderateMetoclopramide + Cyclosporine
"Metoclopramide can cause an increase in the absorption of Cyclosporine resulting in an increased serum concentration and potentially a worsening of adverse effects."
Clinical Note
moderateTerminal elimination half-life is approximately 8 hours in healthy subjects, supporting twice-daily dosing.
Renal (50-70% as unchanged drug and metabolites); fecal (20-30%); biliary (minor ~5%)
Primarily hepatobiliary and fecal elimination; approximately 85% of absorbed dose recovered in feces (mostly as metabolites) and <4% in urine as unchanged drug.
Category C
Category C
Antiemetic/Prokinetic Agent
Prokinetic Agent
Metoclopramide + Clotrimazole
"The metabolism of Clotrimazole can be decreased when combined with Metoclopramide."